Literature DB >> 28209480

Thermal stabilization of anti-α-cobratoxin single domain antibodies.

George P Anderson1, Jessica H Liu2, Dan Zabetakis3, Jinny L Liu3, Ellen R Goldman3.   

Abstract

There is an unmet need for snake antivenoms that can be stored ready to use near the point of care. To address that need we have taken two anti-α-cobratoxin single domain antibodies and increased their thermal stability to improve their ambient temperature shelf-life. The anti-α-cobratoxin single domain antibodies C2 and C20 were first isolated, and demonstrated to be toxin neutralizing by Richard et al., 2013 (Richard, G., Meyers, A.J., McLean, M.D., Arbabi-Ghahroudi, M., MacKenzie, R., Hall, J.C., 2013. In vivo neutralization of alpha-cobratoxin with high-affinity llama single-domain antibodies (VHHs) and a VHH-Fc antibody. PLoS One 8, e69495). To thermal stabilize C2 and C20, we first made changes to their frame work 1 region that we had previously identified to be stabilizing, as well as reverted to the hallmark amino acids highly conserved in VHH domains; these changes improved their melting temperature (Tm) by 2 and 6 °C respectively. The further addition of a non-canonical disulfide bond raised the Tm an additional 13 and 9 °C respectively; giving final Tm values of 86 and 75 °C. Testing these mutants at 1 mg/mL at a range of elevated temperatures for an hour; we found that at 65 °C the wild type C2 and C20 had lost 35 and 95% of their binding activity respectively, while the mutants with the added disulfide bond retained nearly 100% of their initial binding activity. While significant work remains to formulate and field a shelf-stable antivenom, our results indicate such a product should be attainable in the near future. Published by Elsevier Ltd.

Entities:  

Keywords:  Antivenoms; Cobratoxin; Naja naja kaouthia; Single domain antibody; Snake venoms; Thermal stability

Mesh:

Substances:

Year:  2017        PMID: 28209480     DOI: 10.1016/j.toxicon.2017.02.008

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  11 in total

1.  Evaluation of a noncanonical Cys40-Cys55 disulfide linkage for stabilization of single-domain antibodies.

Authors:  Dae Young Kim; Hiba Kandalaft; Greg Hussack; Shalini Raphael; Wen Ding; John F Kelly; Kevin A Henry; Jamshid Tanha
Journal:  Protein Sci       Date:  2019-03-14       Impact factor: 6.725

2.  Structure and development of single domain antibodies as modules for therapeutics and diagnostics.

Authors:  Robert J Hoey; Hyeyoung Eom; James R Horn
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-09

3.  Safety and efficacy of a freeze-dried trivalent antivenom for snakebites in the Brazilian Amazon: An open randomized controlled phase IIb clinical trial.

Authors:  Iran Mendonça-da-Silva; Antônio Magela Tavares; Jacqueline Sachett; José Felipe Sardinha; Lilian Zaparolli; Maria Fátima Gomes Santos; Marcus Lacerda; Wuelton Marcelo Monteiro
Journal:  PLoS Negl Trop Dis       Date:  2017-11-27

4.  Exploiting sequence and stability information for directing nanobody stability engineering.

Authors:  Patrick Kunz; Tilman Flock; Nicolas Soler; Moritz Zaiss; Cécile Vincke; Yann Sterckx; Damjana Kastelic; Serge Muyldermans; Jörg D Hoheisel
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-06-20       Impact factor: 3.770

Review 5.  Enhancing Stability of Camelid and Shark Single Domain Antibodies: An Overview.

Authors:  Ellen R Goldman; Jinny L Liu; Dan Zabetakis; George P Anderson
Journal:  Front Immunol       Date:  2017-07-25       Impact factor: 7.561

6.  The structural basis of nanobody unfolding reversibility and thermoresistance.

Authors:  Patrick Kunz; Katinka Zinner; Norbert Mücke; Tanja Bartoschik; Serge Muyldermans; Jörg D Hoheisel
Journal:  Sci Rep       Date:  2018-05-21       Impact factor: 4.379

Review 7.  Toxin Neutralization Using Alternative Binding Proteins.

Authors:  Timothy Patrick Jenkins; Thomas Fryer; Rasmus Ibsen Dehli; Jonas Arnold Jürgensen; Albert Fuglsang-Madsen; Sofie Føns; Andreas Hougaard Laustsen
Journal:  Toxins (Basel)       Date:  2019-01-17       Impact factor: 4.546

Review 8.  The Urgent Need to Develop Novel Strategies for the Diagnosis and Treatment of Snakebites.

Authors:  Harry F Williams; Harry J Layfield; Thomas Vallance; Ketan Patel; Andrew B Bicknell; Steven A Trim; Sakthivel Vaiyapuri
Journal:  Toxins (Basel)       Date:  2019-06-20       Impact factor: 4.546

Review 9.  Recent Advances in Next Generation Snakebite Antivenoms.

Authors:  Cecilie Knudsen; Andreas H Laustsen
Journal:  Trop Med Infect Dis       Date:  2018-04-15

10.  Selection and Characterization of CSFV-Specific Single-Domain Antibodies and Their Application along with Immunomagnetic Nanobeads and Quantum Dots.

Authors:  Shunli Yang; Li Yuan; Youjun Shang; Jinyan Wu; Xiangtao Liu; Jie Zhang; Zygmunt Pejsak; Katarzyna Podgórska; Katarzyna Stepniewska; Muhammad Umar Zafar Khan; Jianping Cai; Shuanghui Yin
Journal:  Biomed Res Int       Date:  2020-01-30       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.